An update on treatment of higher risk myelodysplastic syndromes
Sign Up to like & getrecommendations! Published in 2019 at "Expert Review of Hematology"
DOI: 10.1080/17474086.2018.1537777
Abstract: ABSTRACT Introduction: Myelodysplastic syndromes (MDS) are clonal stem cell disorders mostly affecting the elderly. They are classified into lower and higher risk MDS according to prognostic scoring systems. In higher risk patients, treatments should aim… read more here.
Keywords: myelodysplastic syndromes; risk; update treatment; higher risk ... See more keywords